Connecting you to content on EBSCOhost

Works by Humphreys, William Griffith

Results: 3

1

Clinical significance of CYP2C19 polymorphisms on the metabolism and pharmacokinetics of 11β-hydroxysteroid dehydrogenase type-1 inhibitor BMS-823778.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 130, doi. 10.1111/bcp.13421

By:

Cheng, Yaofeng;
Wang, Lifei;
Iacono, Lisa;
Zhang, Donglu;
Chen, Weiqi;
Gong, Jiachang;
Humphreys, William Griffith;
Gan, Jinping

Publication type:

Article

2

The influence of kidney function on dapagliflozin exposure, metabolism and pharmacodynamics in healthy subjects and in patients with type 2 diabetes mellitus.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 432, doi. 10.1111/bcp.12056

By:

Kasichayanula, Sreeneeranj;
Liu, Xiaoni;
Pe Benito, Melanie;
Yao, Ming;
Pfister, Marc;
LaCreta, Frank P.;
Humphreys, William Griffith;
Boulton, David W.

Publication type:

Article

3

Repaglinide-gemfibrozil drug interaction: inhibition of repaglinide glucuronidation as a potential additional contributing mechanism J. Gan et al. Inhibition of repaglinide glucuronidation by gemfibrozil and its glucuronide.

Published in:

British Journal of Clinical Pharmacology, 2010, v. 70, n. 6, p. 870, doi. 10.1111/j.1365-2125.2010.03772.x

By:

Gan, Jinping;
Chen, Weiqi;
Shen, Hong;
Gao, Ling;
Hong, Yang;
Tian, Yuan;
Li, Wenying;
Zhang, Yueping;
Tang, Yuwei;
Zhang, Hongjian;
Humphreys, William Griffith;
Rodrigues, A. David

Publication type:

Article